1. Blomgren, H., Cantell, K., Johansson, B., Lagergren, C., Ringborg, U., Strander, H., Interferon therapy in Hodgkin's disease. Acta Med. Scand.199 (1976), 527?532.
2. Boëthius, J., Blomgren, H., Collins, V. P., Greitz, T., Strander, H., The Effect of Systemic Human Interferon-Alpha Administration to Patients with Glioblastoma Multiforme. Acta Neurochir. (Wien)68 (1983), 239?251.
3. Ezaki, K., Okabe, K., Inagaki, J., Horikoshi, N., Inoue, K., Aiba, K., Domyo, M., Nagata, T., Ogawa, M., Clinical study of human fibroblast interferon. Gan To Kagakuryoho.9 (1982), 31?37.
4. Ezaki, K., Okabe, K., Domyo, M., Abe, K., Ogawa, M., Immunological studies in patients with malignant diseases under treatment of human fibroblast interferon. Gan To Kagakuryoho.9 (1982), 238?243.
5. Gresser, I., Anti tumor effects of interferon. Adv. Cancer Res.16 (1972), 97?140.